English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52880444    線上人數 :  655
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"ou h t"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 21-28 / 28 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-09-29T01:47:36Z Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species Ou H.-T.; Lee T.-Y.; YEE-CHUN CHEN; Charbonneau C.
臺大學術典藏 2020-02-25T09:06:06Z Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria Hsu, F.-Y.; FANG-JU LIN; Ou, H.-T.; Huang, S.-H.; Wang, C.-C.
國立成功大學 2020 Author reply to Letter to Editor “Quality of life and pregnancy outcomes among women undergoing in vitro fertilization treatment: A longitudinal cohort study” Wu, M.-H.;Ou, H.-T.
國立成功大學 2020 Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan’s health care system Lee, T.-Y.;Chen, H.-Y.;Chen, T.-Y.;Li, S.-S.;Fang, W.-T.;Wen, Y.-C.;Lo, Y.-W.;Ou, H.-T.
國立成功大學 2018 Validation of the 5-item medication adherence report scale in older stroke patients in Iran Lin, C.-Y.;Ou, H.-T.;Nikoobakht, M.;Brostr�m, A.;�restedt, K.;Pakpour, A.H.
國立成功大學 2018 Comparative risks of diabetes-related complications of basal insulins: a longitudinal population-based cohort of type 1 diabetes 1999–2013 in Taiwan Ou, H.-T.;Lee, T.-Y.;Du, Y.-F.;Li, C.-Y.
國立成功大學 2015-05 COST-EFFECTIVENESS ANALYSIS OF SECOND-LINE AND THIRD-LINE ANTIDIABETIC DRUGS IN TYEP 2 DIABETES: AN EMPIRICAL, POPULATION-BASED OBSERVATIONAL STUDY FROM TAIWAN Ou, H. T.; Balkrishnan, R.; Yang, C. Y.; Chang, K. C.
大葉大學 2005-01 The antiproliferative and differentiating effects of human leukemic U937 cells are mediated by cytokines from activated mononuclear cells by dietary mushrooms Ou, H.-T.;Chen, Y.-J.;Chang, H.-M.

顯示項目 21-28 / 28 (共1頁)
1 
每頁顯示[10|25|50]項目